Sanofi-aventis Acquires Production and Sales Rights to Antiplatelet Agent Plavix from Daiichi Pharmaceutical.Tokyo, Japan, Mar 1, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Sanofi-aventis announced on March 1 that it has acquired the rights to produce and sell Plavix Plavix ® Clopidogrel bisulfate Cardiology An antiplatelet agent used to ↓ risk of stroke, acute MI, or vascular death in Pts with known ASHD. See CAPRIE. , an antiplatelet agent antiplatelet agent Therapeutics Any agent–eg, aspirin, that ↓ platelet clumping and clotting , from Daiichi Pharmaceutical. Initially approved by the US Food and Drug Administration in 1997, Plavix is prescribed pre·scribe v. pre·scribed, pre·scrib·ing, pre·scribes v.tr. 1. To set down as a rule or guide; enjoin. See Synonyms at dictate. 2. To order the use of (a medicine or other treatment). to patients suffering from atherothrombosis. Sanofi-aventis and Daiichi Pharmaceutical will continue to collaborate on the promotion of Plavix in Japan. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion